Aristotle Capital Boston, LLC
-0.91%
3か月リターン
$39.190
-0.247 (-0.63%)終値時点
Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations.
Guardian Pharmacy Services Inc is a good buy right now, trading at $39.44, which is significantly below the analyst consensus target of $49.81. The stock has shown strong growth, with a year-to-date change of +33.56% and a 1-year change of +35.77%. The forward P/E ratio of 30.21 suggests reasonable growth expectations, while the gross margin has improved to 22.75%. However, the RSI is at 42.11, indicating it is nearing oversold territory, which could present a buying opportunity.

Keybanc Initiates Coverage of Guardian Pharmacy Services with Overweight Rating

Latest Wall Street Ratings Overview

Guardian Pharmacy Acquires Nautilus Pharmacy Assets to Enhance LTC Services

Guardian Pharmacy Services to Participate in Jefferies Healthcare Conference

Guardian Pharmacy Services (GRDN) Q2 2026 Earnings Call Transcript
Guardian Pharmacy Services, Inc. is a pharmacy services company. The Company provides a range of technology-enabled services designed to help residents of long-term care facilities (LTCFs) adhere to drug regimen. It offers compliance packaging service for repackaging and dispensing prescription and non-prescription pharmaceuticals in accordance with physician orders and delivers the medications to LTCFs for administration to individual residents. It organizes each resident’s medications into individual unit dose or multi-unit dose packaging in accordance with specific drug distribution rounds that occur at LTCFs at specific times throughout the day. Its pharmacy workflow software helps to manage and track drug dispensing via a structured and scalable workflow process, including the use of barcode technology. It offers Guardian Compass, which includes dashboards created to help local pharmacies plan, track and optimize business operations. It operates in the Consumer Non-Cyclicals sector.
Guardian Pharmacy Services Inc is a good buy right now, trading at $39.44, which is significantly below the analyst consensus target of $49.81. The stock has shown strong growth, with a year-to-date change of +33.56% and a 1-year change of +35.77%. The forward P/E ratio of 30.21 suggests reasonable growth expectations, while the gross margin has improved to 22.75%. However, the RSI is at 42.11, indicating it is nearing oversold territory, which could present a buying opportunity.
投稿はまだありません
登録またはログインして議論に参加本ページは調査目的であり、投資助言ではありません。モデルは誤ることがあります。過去の実績は将来の成果を保証しません。